Withdrawal of immunosuppresive agents in the treatment of disseminated coccidioidomycosis.
Disseminated coccidioidomycosis is a systemic fungal infection that causes high mortality in the renal transplatn patient. Cell-mediated immunity, which appears to be the relevant host defense mechanism, is impaired by the immunosupressive agents used to prevent allograft rejection. In the case presented, immunosuppressive therapy was stopped as an adjunct to treatment of this infection. The patient has shown evidence of improvement, and his allograft has continued to function nine months after the withdrawal of immunosuppressive therapy and 18 months after the diagnosis. In vitro lymphocyte function studies indicate that the impairment in cell-mediated immunity detected prior to withdrawal of immunosuppressive therapy has persisted, probably accounting for allograft survival. Withdrawal of immunosuppressive therapy may prolong survival in renal transplant patients with disseminated coccidioidomycosis. Additionally, depression in cell-mediated immunity associated with the fungal infection itself may be sufficient to prevent allograft rejection in these patients.
D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D001379:Azathioprine / Q000008:administration & dosage* / Q000627:therapeutic use; D003047:Coccidioidomycosis / Q000276:immunology / Q000628:therapy*; D006084:Graft Rejection / Q000187:drug effects; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D016030:Kidney Transplantation; D008297:Male; D014184:Transplantation, Homologous
D000666:Amphotericin B; D001379:Azathioprine